to Highlight Innovation and Opportunity in Kidney Health NEW YORK, Feb. 4, 2021 - Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney diseases to drive improved patient outcomes and advance value-based care, announced today that it will co-host a Capital Markets Day for Kidney Health with the American Society of Nephrology (ASN) on Thursday, February 11 from 8:00 a.m. - 12:30 p.m. EST. The virtual event will bring together a broad group of delegates representing the kidney community, including leading clinicians, representatives of U.S. government health agencies, kidney care innovators and investors focused on life sciences and medical technology, for a series of presentations and panel discussions on the challenges and innovations arising from kidney health and the market opportunity in this area.
American Society of Nephrology and Renalytix to Co-Host Virtual Capital Markets Day for Kidney Health
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.
Sakaryalı okulun etwinning projesi 39 ülkeden tercih edildi - HaberFlash :: internet haber sitesi
haberflash.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from haberflash.com Daily Mail and Mail on Sunday newspapers.